Evidence map›Paper›PMID 38444543›Full record

ArticleJournal of frailty, sarcopenia and falls2024

3D Topographical Scanning for the Detection of Osteoporosis.

Clayton W Maschhoff, Yousi Oquendo, John B Michaud, David Carey, Christopher Jamero, Julius A Bishop, Christopher Jin, Malcolm DeBaun, Michael J Gardner

Open access · goldAbstract read
In one paragraph

Article in Journal of frailty, sarcopenia and falls, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Clayton W MaschhoffDepartment of Orthopaedic Surgery, Stanford University Medical Center, Stanford, CA, USA.
Yousi OquendoDepartment of Orthopaedic Surgery, Stanford University Medical Center, Stanford, CA, USA.
John B MichaudDepartment of Orthopaedic Surgery, Stanford University Medical Center, Stanford, CA, USA.
David CareyDepartment of Orthopaedic Surgery, Stanford University Medical Center, Stanford, CA, USA.
Christopher JameroDepartment of Orthopaedic Surgery, Stanford University Medical Center, Stanford, CA, USA.
Julius A BishopDepartment of Orthopaedic Surgery, Stanford University Medical Center, Stanford, CA, USA.
Christopher JinDepartment of Orthopaedic Surgery, Stanford University Medical Center, Stanford, CA, USA.
Malcolm DeBaunDepartment of Orthopaedic Surgery, Duke University, Durham, NC, USA.
Michael J GardnerDepartment of Orthopaedic Surgery, Stanford University Medical Center, Stanford, CA, USA.
Stanford Medicine · USStanford University · USDuke University Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Osteoporosis is associated with greater risk of fracture, which can lead to increased morbidity and mortality. DEXA scans are often inaccessible for patients, leaving many cases of osteoporosis undetected. A portable 3D topographical scan offers an easily accessible and inexpensive potential adjunct screening tool. We hypothesized that 3D scanning of arm and calf circumference and volume would correlate with DEXA T-scores. Methods: 96 female patients were enrolled. Patients were consented and completed a topographical scan of bilateral arms and lower legs with a mobile 3D scanner for arm and calf circumference and volume in clinic. Patient charts were then retrospectively reviewed for DEXA T-scores. Results: Forearm DEXA T-score was positively correlated with arm circumference (r = 0.49, p<0.01), arm volume (r=0.62, p<0.01), and calf volume (r=0.47, p<0.01). Femoral neck DEXA T-score was positively correlated with calf circumference (r=0.36, p<0.01) and calf volume (r=0.36, p<0.01). Conclusions: Our results showed significant correlations between DEXA T-scores and topographical measurements from mobile device acquired 3D scans, although these were in the "moderate" range. Mobile device-based 3D scanning may hold promise as an adjunct screening tool for osteoporosis when DEXA scanning is not available or feasible for patients, although further studies are needed to elucidate the full potential of its clinical utility. At a minimum, identifying a patient as high risk may promote earlier diagnostic DEXA scanning.

Indexed as

DEXAFracture preventionOsteoporosisSarcopeniaScreening

Identifiers

PMID38444543
PMCPMC10910256
OpenAlexW4392283615

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.